Simplex Trading »

Neurogene shares owned by Simplex Trading

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Simplex Trading from 13F filings

Historical chart of Simplex Trading investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Simplex Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Simplex Trading

Quarter filed Position value Share count Share price at filing
2025-09-30 $21k 1.2k 17.02
2025-06-30 $25k 1.7k 14.61
2025-03-31 $9.0k 845 10.65

More positions owned by Simplex Trading

Spdr S&p 500 Etf Tr Put Put Option
Spdr S&p 500 Etf Tr Call Call Option
Invesco Qqq Tr Put Put Option
Tesla Put Put Option
Nvidia Corporation Put Put Option
Tesla Call Call Option
Invesco Qqq Tr Call Call Option
Nvidia Corporation Call Call Option
Ishares Tr Put Put Option
Ishares Tr Call Call Option
Spdr Gold Tr Call Call Option
Apple Put Put Option
Alphabet Call Call Option
Apple Call Call Option
Meta Platforms Call Call Option

View all positions for Simplex Trading

Top funds holding Neurogene

Samsara BioCapital
Rtw Investments
Redmile Group
Casdin Capital
EcoR1 Capital
Baker Bros. Advisors
BlackRock
Balyasny Asset Management
Toronto-Dominion Bank
Vanguard Group
Arrowpoint Asset Management
Morgan Stanley
Dr. Jeffrey R. Jay, M.D.
Jennison Associates
Octagon Capital Advisors

View all funds holding Neurogene